DDMAC says promo pieces were Rythmol SR were misleading

DDMAC says two promotional pieces for Reliant Pharmaceuticals' Rythmol SR were false or misleading because they failed to include any risk information and they broadened the indication for the product.

James G. Dickinson

November 1, 2006

5:00 am

DDMAC says two promotional pieces for Reliant Pharmaceuticals’ Rythmol SR were false or misleading because they failed to include any risk information and they broadened the indication for the product. A corrective message campaign was requested.

From the November 01, 2006 Issue of MM+M - Medical Marketing and Media

From Our Partners

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.

Partner Content

The new brand.com experience

How healthcare manufacturers can improve customer engagement, drive high-value activity and inform future strategy with conversational AI.

Shifting market trends are transforming how pharma marketers find, target and engage with patients and providers

Partner Content

Shifting market trends are transforming how pharma marketers find, target and engage with patients and providers

The Healthcare Marketers Trend Survey shows that, as far as channel usage goes, more growth occurred in newer tactics like non-linear video and streaming audio than in some of the more traditional ones.

A Big C Shift: Rebranding cancer to reflect advances in oncology

Partner Content

A Big C Shift: Rebranding cancer to reflect advances in oncology

Pivoting people’s perception of the disease to match the realities of treatment.